About

Publications While At HealthPartners

Highlights

selected publications

Journal Article

Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial. 

Journal for immunotherapy of cancer. 2024

Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC. 

New England Journal of Medicine. 2018

Contact

full name

D. R. Spigel

Quick Info

Publications

Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.

Collaboration

Co-author network

Map of science